New Cardinal Health report examines shifts in biosimilars industry
- Wednesday, February 22, 2023, 7:12
- PR Newswire
- Add a comment
Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb. 22, 2023 /PRNewswire/ — Today, Cardinal Health (NYSE: CAH) released its 2023 Biosimilars…
About the Author
admin has written 20655 stories on this site.